Clinical Trials Logo

Zoster clinical trials

View clinical trials related to Zoster.

Filter by:
  • None
  • Page 1

NCT ID: NCT06001606 Recruiting - Clinical trials for Systemic Lupus Erythematosus

Immunogenicity, Reactogenicity of Shingrix in SLE

Start date: May 8, 2023
Phase: Phase 3
Study type: Interventional

To investigate the immunogenicity, reactogenicity and safety of 2 doses of the adjuvanted herpes zoster subunit vaccine (Shingrix) in patients with SLE in a randomized trial.

NCT ID: NCT05596526 Recruiting - Shingles Clinical Trials

Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients

MSHINGVAX
Start date: December 1, 2022
Phase: Phase 4
Study type: Interventional

The purpose of this study is to provide evidence as to whether RZV is immunogenic with an acceptable safety profile in Multiple Sclerosis patients on anti-CD20 treatment.

NCT ID: NCT04047979 Completed - Shingles Clinical Trials

Systems Biology of Zoster Vaccine

Start date: November 14, 2019
Phase: Phase 2
Study type: Interventional

The purpose of the study is to better understand how the immune system responds to the new herpes zoster (shingles) vaccine (Shingrix®). The study will be looking at certain markers in the blood after vaccination with Shingrix®.

NCT ID: NCT01684072 Completed - Chickenpox Clinical Trials

Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin

Start date: January 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to observe the occurrence of adverse reaction and antibody positive rate, the elevated level of antibody,Geometric mean titer (GMT) between groups of live attenuated varicella vaccine without gelatin.